BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...million in a series B round led by Symbiosis II LLC, with participation from new investors Solasta Ventures...
...Capital Woodline Partners Logos Capital Janus Henderson Investors Atlas Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon...
BioCentury | May 21, 2020
Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

...led the series B funding, which included new investors Tekla Capital Management, MRL Ventures Fund, Solasta Ventures...
...Therapeutics LLC, where he was chief business officer from 2010-15. The investor group also includes Solasta Ventures...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...Global Investors, TPG Capital’s The Rise Fund, F-Prime Capital, funds managed by Tekla Capital Management, Solasta Ventures...
BioCentury | Mar 2, 2020
Finance

Xilio to deploy $100M B round toward POC for tumor-activated immunotherapies

...fellow new investors SV Health Investors, MRL Ventures Fund, RiverVest Venture Partners, Bay City Capital, Solasta Ventures...
Items per page:
1 - 4 of 4
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...million in a series B round led by Symbiosis II LLC, with participation from new investors Solasta Ventures...
...Capital Woodline Partners Logos Capital Janus Henderson Investors Atlas Venture Abingworth Kira Pharmaceuticals RA Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon...
BioCentury | May 21, 2020
Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

...led the series B funding, which included new investors Tekla Capital Management, MRL Ventures Fund, Solasta Ventures...
...Therapeutics LLC, where he was chief business officer from 2010-15. The investor group also includes Solasta Ventures...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...Global Investors, TPG Capital’s The Rise Fund, F-Prime Capital, funds managed by Tekla Capital Management, Solasta Ventures...
BioCentury | Mar 2, 2020
Finance

Xilio to deploy $100M B round toward POC for tumor-activated immunotherapies

...fellow new investors SV Health Investors, MRL Ventures Fund, RiverVest Venture Partners, Bay City Capital, Solasta Ventures...
Items per page:
1 - 4 of 4